慢性和急性呼吸衰竭移植后严重的初级移植功能障碍的对比预测因素
Chitaru Kurihara1, Taisuke Kaiho1, Benjamin Thomae1
1Division of Thoracic Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Journal of thoracic disease
|September 13, 2024
概括
肺移植的结果在急性呼吸窘迫综合征 (ARDS) 和慢性呼吸衰竭患者之间有所不同. ARDS患者面临更高的初级移植功能障碍 (PGD) 风险,年龄和白蛋白作为关键预测因素,与非ARDS患者不同,缺血时间至关重要.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 移植手术 移植手术
背景情况:
- 肺移植对于末期肺病至关重要,人们对其在急性呼吸困扰综合征 (ARDS) 患者的应用越来越感兴趣,特别是在COVID-19后.
- 主要移植功能障碍 (PGD) 在接受肺移植的ARDS患者中比慢性呼吸衰竭患者更频繁,尽管风险因素尚未完全理解.
- 这项回顾性研究旨在确定ARDS患者与非ARDS肺移植受体中PGD3级的独特风险因素.
研究的目的:
- 调查和对比与患有ARDS的肺移植接受者与慢性呼吸衰竭患者发展初级移植功能障碍 (PGD) 3级相关的风险因素.
- 在这两个不同的肺移植患者群体中,确定预测PGD 3级的特定临床变量.
主要方法:
- 在2018年1月至2023年6月期间,对293名肺移植接受者的回顾性分析.
- 多变量逻辑回归分析被用于识别PGD3级的预测因素,利用通过单变量分析识别的变量.
主要成果:
- 与非ARDS患者 (9.6%) 相比,ARDS患者 (30.2%) 的PGD 3级发病率明显高于非ARDS患者 (9.6%) (P<0.001).
- 在非ARDS患者中,缺血时间是PGD 3级的显著预测因素 (OR=0.60;P=0.01).
- 对于ARDS患者,年龄 (OR=0.72;P=0.048) 和手术前的白蛋白水平 (OR <0.01;P=0.042) 被确定为PGD 3.级的显著预测因素.
- 在ARDS和非ARDS组之间没有观察到移植后生存的显著差异.
结论:
- 患有ARDS的肺移植接受者和患有慢性呼吸衰竭的接受者对发展严重的原发性移植功能障碍 (PGD) 具有不同的风险概况.
- 这些发现强调了为接受肺移植的ARDS患者制定量身定制的治疗策略的必要性,以减轻PGD风险.
- 需要进一步的研究来完善旨在减少PGD发病率和改善这些不同患者队列的移植结果的干预措施.
相关概念视频
01:29Acute Respiratory Failure-V
124
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
124
01:21Acute Respiratory Failure-II
183
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
183
01:21Acute Respiratory Failure-I
178
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
178
01:24Tissue Transplantation
343
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
343